A Trial Comparing SGC and Conventional Empiric Treatment for Glucose Control in Critically Ill Patients With Mechanical Ventilation in ICU

NCT ID: NCT02491346

Last Updated: 2015-07-08

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: PHASE4
• Total Enrollment: 46 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2014-10-31
• Study Completion Date: 2015-09-30

Brief Summary

Poor glycemic control in critically ill patients can increase their mortality, while safe and efficient glucose control is laborious and time-consuming. The Space GlucoseControl which is installed with eMPC(enhanced Model Predictive Control) can get the blood glucose target range safely and effectively through regulating insulin dose rate. This study is a random controlled trial involving the patients with mechanical ventilation in intensive care unit in order to evaluate the difference of safety and efficacy of blood glucose control between SGC directed and conventional treatment. At last, the trial results can determine whether the Space GlucoseControl can control blood glucose safely and effectively in the patients with mechanical ventilation in intensive care units.

Detailed Description

Design: The study was conducted as a single-centre, open randomized controlled, parallel trial.

Study population: Adult medical ICU patients who were mechanically ventilated and assumed to require at least 3 days of intensive care were recruited. Patients fulfilling the inclusion criterion of glucose≥9.0 mM were randomly assigned using serially numbered to either the intervention group (BG control by SGC) or the control group (conventional empiric BG management). The both group aim to establish the BG levels 5.8-8.9mM.

Study protocol: BG measurements were performed using glucometer to test the fingertip capillary blood sample for the BG levels. As for patients with shock or required vasopressor, arterial BG was sampled to measure through the glucometer. Insulin [40 IU of Actrapid HM (Wanbang Biopharmaceuticals, Jiangsu province, China)/40ml of 0.9% sodium chloride] was infused intravenously applying the standard perfusor of the ICU (Perfusor®Space, B. Braun Melsungen AG, Melsungen, Germany). All trial-related activities were carried out until the end of the patient's ICU stay, or for a period of 72 hours. Meanwhile, enteral and parenteral nutrition was administrated to patients according to their condition.

Statistical analysis was performed on an intention-to-treat basis. The percentage of values in the target range (5.8-8.9mM) was defined as primary end point for the assessment of glucose control. Data are reported as mean±SD values if not otherwise indicated. Data analysis was performed using SPSS19.0.

Conditions

Hyperglycemia; Respiratory Failure; Critical Illness

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

conventional empirical glycemic control

the patients' blood glucose is controlled by physician according to their experience through insulin subcutaneous injection or insulin continuous infusion whose dosage is determinated by the physician.

Group Type: ACTIVE_COMPARATOR

conventional empirical glycemic control

Intervention Type: PROCEDURE

the patients' blood glucose is controlled by physician according to their experience through insulin subcutaneous injection or insulin continuous infusion whose dosage is determinated by the physician.

SGC directed glycemic control

the patients' blood glucose is controlled by SGC system through insulin continuous infusion whose dosage is determinated by SGC.

Group Type: EXPERIMENTAL

SGC directed glycemic control

Intervention Type: PROCEDURE

the patients' blood glucose is controlled by SGC system through insulin continuous infusion whose dosage is determinated by SGC.

Interventions

conventional empirical glycemic control

the patients' blood glucose is controlled by physician according to their experience through insulin subcutaneous injection or insulin continuous infusion whose dosage is determinated by the physician.

Intervention Type: PROCEDURE

SGC directed glycemic control

the patients' blood glucose is controlled by SGC system through insulin continuous infusion whose dosage is determinated by SGC.

Intervention Type: PROCEDURE

Other Intervention Names

comparator group; SGC group

Eligibility Criteria

Inclusion Criteria

1. Admitted to the ICU

2. At least one BG measurement 9.0mmol/L or higher

3. Expected to stay in ICU ≥3 days;

4. Mechanical ventilation

Exclusion Criteria

1. Aged < 18 years;

2. Admitted because of diabetic ketoacidosis or nonketotic hyperosmolar state

3. Pregnant

4. In a state in which death was perceived as imminent

5. Without written informed consent

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Peking Union Medical College Hospital

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Bin Du, Dr

Role: PRINCIPAL_INVESTIGATOR

MICU of Peking Union Medical College Hospital

Locations

MICU of Peking Union Medical College Hospital

Beijing, Beijing Municipality, China

Site Status: RECRUITING

Countries

China

Central Contacts

Bin Du, Dr.

Role: CONTACT

dubin98@gmail.com

86-010-69155046

Facility Contacts

Bin Du, Dr

Role: primary

dubin98@gmail.com

86-010-69155046

References

Xu B, Jiang W, Wang CY, Weng L, Hu XY, Peng JM, Du B. Comparison of Space Glucose Control and Routine Glucose Management Protocol for Glycemic Control in Critically Ill Patients: A Prospective, Randomized Clinical Study. Chin Med J (Engl). 2017 Sep 5;130(17):2041-2049. doi: 10.4103/0366-6999.213422.

Reference Type: DERIVED

PMID: 28836546 (View on PubMed)

Other Identifiers

MICU_2014-11

Identifier Type: -

Identifier Source: org_study_id